EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Topical and oral emodepside formulations for last-line treatment of multianthelmintic drug-resistant hookworms when given orally to dogs are not bioequivalent

Theresa A Quintana iD, Greta N Karwath, Erin J Mayhue, Maria C Jugan iD, Jeba R J Jesudoss Chelladurai iD, Stephanie E Martinez iD

American Journal of Veterinary Research · 2025

DOI: 10.2460/ajvr.25.01.0027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2025. Verfasst von Theresa A Quintana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS. Hauptthemen laut MEDLINE: Dog Diseases, Depsipeptides, Hookworm Infections, Anthelmintics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the pharmacokinetics of emodepside in dogs following single-dose administration of the FDA-approved feline topical solution orally and topically and the European Medicines Agency–approved canine modified-release tablet orally and to assess the bioequivalence of the feline topical solution administered orally compared to the canine modified-release tablet.

Methods

This study was conducted in 3 phases, during which dogs received single doses of emodepside as the feline topical solution (1 mg/kg) orally, the canine modified-release tablet (1 mg/kg) orally, and the topical feline solution (3 mg/kg) topically. Plasma pharmacokinetic profiles were determined for 21 days postdose. Bioequivalence testing was conducted for orally administered emodepside.

Results

7 healthy client-owned dogs (4 female and 3 male) were prospectively enrolled in this crossover study from May through August 2023. Oral administration of the feline topical solution resulted in markedly greater emodepside absorption than the modified-release tablet and was not bioequivalent. Emodepside plasma concentrations following topical administration of the FDA formulation were 36- to 122-fold lower than after oral administration.

Conclusions

The feline topical solution administered orally at 1 mg/kg is not bioequivalent to the canine modified-release tablet. Markedly higher absorption of the feline topical solution administered orally raises potential safety concerns for extralabel use in dogs to treat multianthelmintic drug-resistant hookworm infections. Poor absorption following topical administration suggests it may be unsuitable for treating multianthelmintic drug-resistant hookworm infections. Clinical Relevance These findings highlight potential emodepside toxicity risks with extralabel use of the FDA-approved topical feline product and help inform safe off-label use in dogs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesDepsipeptidesHookworm InfectionsAnthelminticsAnimalsDogsAdministration, OralMaleFemaleAdministration, TopicalCross-Over StudiesTherapeutic EquivalencyDrug ResistanceAncylostomatoideaTablets

Stichwörter der Autor:innen

bioequivalencedogsemodepsidepharmacokineticsresistant hookworms

Substanzen

DepsipeptidesemodepsideAnthelminticsTablets

Autor:innen und Institutionen

  • Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS.
  • Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL.
  • Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS.
  • Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS.
  • Department of Veterinary Clinical and Life Sciences, College of Veterinary Medicine, Utah State University, Logan, UT.

ORCID-Profile: Theresa A Quintana, Maria C Jugan, Jeba R J Jesudoss Chelladurai, Stephanie E Martinez

Zitieren

APA

Quintana, T. A., Karwath, G. N., Mayhue, E. J., Jugan, M. C., Jesudoss Chelladurai, J. R. J., & Martinez, S. E. (2025). Topical and oral emodepside formulations for last-line treatment of multianthelmintic drug-resistant hookworms when given orally to dogs are not bioequivalent. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.25.01.0027

Vancouver

Quintana TA, Karwath GN, Mayhue EJ, Jugan MC, Jesudoss Chelladurai JRJ, Martinez SE. Topical and oral emodepside formulations for last-line treatment of multianthelmintic drug-resistant hookworms when given orally to dogs are not bioequivalent. American Journal of Veterinary Research. 2025. doi:10.2460/ajvr.25.01.0027

BibTeX
@article{Quintana2025,
  author = {Quintana, Theresa A and Karwath, Greta N and Mayhue, Erin J and Jugan, Maria C and Jesudoss Chelladurai, Jeba R J and Martinez, Stephanie E},
  title = {Topical and oral emodepside formulations for last-line treatment of multianthelmintic drug-resistant hookworms when given orally to dogs are not bioequivalent},
  journal = {American Journal of Veterinary Research},
  year = {2025},
  doi = {10.2460/ajvr.25.01.0027}
}
Kostenlos starten →